These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Recipient selection algorithm for immunosuppression in cardiac transplantation: OKT3 vs triple therapy alone. Rabinov M; Benson E; Cochrane A; Williams T; Bergin P; Federman J; Esmore D Transplant Proc; 1992 Feb; 24(1):167-8. PubMed ID: 1539226 [No Abstract] [Full Text] [Related]
36. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3. Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852 [No Abstract] [Full Text] [Related]
37. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Opelz G Transplant Proc; 1997; 29(1-2):73-6. PubMed ID: 9123162 [No Abstract] [Full Text] [Related]
38. Preoperative prophylactic OKT3 vs RATG. A randomized clinical study in heart transplant patients. Ippoliti G; Negri M; Abelli P; Rovati B; Di Franco L; Grossi P; Minoli L; Ascari E; Viganó M Transplant Proc; 1991 Aug; 23(4):2272-4. PubMed ID: 1908155 [No Abstract] [Full Text] [Related]
39. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation. Flaman F; Zieroth S; Rao V; Ross H; Delgado DH J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501 [TBL] [Abstract][Full Text] [Related]
40. Acute pulmonary insufficiency due to OKT3 therapy. Büsing M; Mellert J; Greger B; Hopt UT Transplant Proc; 1990 Aug; 22(4):1779-81. PubMed ID: 2117808 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]